Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999 Sep 2. 341(10):738-46. [QxMD MEDLINE Link].
Choudhury P, Chen W, Hunt RC. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. Invest Ophthalmol Vis Sci. 1997 Apr. 38(5):824-33. [QxMD MEDLINE Link].
Stocks SZ, Taylor SM, Shiels IA. Transforming growth factor-beta1 induces alpha-smooth muscle actin expression and fibronectin synthesis in cultured human retinal pigment epithelial cells. Clin Experiment Ophthalmol. 2001 Feb. 29(1):33-7. [QxMD MEDLINE Link].
Nassar K, Lüke J, Lüke M, Kamal M, Abd El-Nabi E, Soliman M. The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Graefes Arch Clin Exp Ophthalmol. 2011 Nov. 249(11):1649-60. [QxMD MEDLINE Link].
Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, van Meurs JC, Tanck MW, Oliver N, et al. The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One. 2008 Jul 16. 3(7):e2675. [QxMD MEDLINE Link]. [Full Text].
Arevalo JF, Maia M, Flynn HW Jr, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol. 2008 Feb. 92(2):213-6. [QxMD MEDLINE Link].
Arevalo JF, Sanchez JG, Saldarriaga L, Berrocal MH, Fromow-Guerra J, Morales-Canton V. Retinal detachment after bevacizumab. Ophthalmology. 2011 Nov. 118(11):2304.e3-7. [QxMD MEDLINE Link].
Rice TA, Michels RG, Rice EF. Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol. 1983 Jan. 95(1):22-33. [QxMD MEDLINE Link].
Thompson JT, de Bustros S, Michels RG, Rice TA. Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula. Arch Ophthalmol. 1987 Apr. 105(4):497-502. [QxMD MEDLINE Link].
Williams DF, Williams GA, Hartz A, Mieler WF, Abrams GW, Aaberg TM. Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique. Ophthalmology. 1989 Jun. 96(6):752-8. [QxMD MEDLINE Link].
Amarnani D, Machuca-Parra AI, Wong LL, Marko CK, Stefater JA, Stryjewski TP, et al. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2017 Aug 1. 58 (10):3940-3949. [QxMD MEDLINE Link].
Sadaka A, Sisk RA, Osher JM, Toygar O, Duncan MK, Riemann CD. Intravitreal methotrexate infusion for proliferative vitreoretinopathy. Clin Ophthalmol. 2016. 10:1811-1817. [QxMD MEDLINE Link].
Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, et al. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease. Am J Ophthalmol. 2016 Jan. 161:36-43.e2. [QxMD MEDLINE Link].
Dikopf MS, Patel KH, Setlur VJ, Lim JI. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment. Eye (Lond). 2015 Sep. 29 (9):1213-9. [QxMD MEDLINE Link].
Berrocal MH. ALL-PROBE VITRECTOMY DISSECTION TECHNIQUES FOR DIABETIC TRACTIONAL RETINAL DETACHMENTS: Lift and Shave. Retina. 2018 Sep. 38 Suppl 1:S2-S4. [QxMD MEDLINE Link].
Cruz-Iñigo YJ, Berrocal MH. Twenty-seven-gauge vitrectomy for combined tractional and rhegmatogenous retinal detachment involving the macula associated with proliferative diabetic retinopathy. Int J Retina Vitreous. 2017. 3:38. [QxMD MEDLINE Link].
Khan MA, Samara WA, Hsu J, Garg S. SHORT-TERM OUTCOMES OF HYBRID 23-, 25-, AND 27-GAUGE VITRECTOMY FOR COMPLEX DIABETIC TRACTIONAL RETINAL DETACHMENT REPAIR. Retin Cases Brief Rep. 2017 Mar 29. [QxMD MEDLINE Link].
Mikhail M, Ali-Ridha A, Chorfi S, Kapusta MA. Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2017 Feb. 255 (2):255-261. [QxMD MEDLINE Link].
Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol. 2008 Jun. 246(6):837-42. [QxMD MEDLINE Link].
Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol. 2008 Feb. 92(2):213-6. [QxMD MEDLINE Link].
Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology. 2009 May. 116(5):927-38. [QxMD MEDLINE Link].
da R Lucena D, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo-Pontes LL. Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study). Br J Ophthalmol. 2009 May. 93(5):688-91. [QxMD MEDLINE Link].
Abrams GW, Williams GA. "En bloc" excision of diabetic membranes. Am J Ophthalmol. 1987 Mar 15. 103(3 Pt 1):302-8. [QxMD MEDLINE Link].
Archives of Ophthalmology. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol. 1992 Jun. 110(6):770-9. [QxMD MEDLINE Link].
Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, double-blind, controlled clinical trial. Ophthalmology. 2001 Jul. 108(7):1179-83. [QxMD MEDLINE Link].
Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Luthert PJ, et al. How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology. 2001 Jul. 108(7):1184-6. [QxMD MEDLINE Link].
Asaria RH, Kon CH, Bunce C, Sethi CS, Limb GA, Khaw PT, et al. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol. 2004 Nov. 88(11):1439-42. [QxMD MEDLINE Link].
Azuma N, Ishikawa K, Hama Y, Hiraoka M, Suzuki Y, Nishina S. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol. 2006 Oct. 142(4):636-43. [QxMD MEDLINE Link].
Blumenkranz M, Hernandez E, Ophir A, Norton EW. 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology. 1984 Feb. 91(2):122-30. [QxMD MEDLINE Link].
Blumenkranz MS, Hartzer MK, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. II. Differing antiproliferative activity of the fluoropyrimidines. Arch Ophthalmol. 1987 Mar. 105(3):396-9. [QxMD MEDLINE Link].
Blumenkranz MS, Ophir A, Claflin AJ, Hajek A. Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol. 1982 Oct. 94(4):458-67. [QxMD MEDLINE Link].
Campochiaro PA, Glaser BM. Endothelial cells release a chemoattractant for retinal pigment epithelial cells in vitro. Arch Ophthalmol. 1985 Dec. 103(12):1876-80. [QxMD MEDLINE Link].
Campochiaro PA, Glaser BM. Mechanisms involved in retinal pigment epithelial cell chemotaxis. Arch Ophthalmol. 1986 Feb. 104(2):277-80. [QxMD MEDLINE Link].
Campochiaro PA, Glaser BM. Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol. 1985 Apr. 103(4):576-9. [QxMD MEDLINE Link].
Campochiaro PA, Jerdan JA, Glaser BM, Cardin A, Michels RG. Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol. 1985 Sep. 103(9):1403-5. [QxMD MEDLINE Link].
Campochiaro PA, Jerdan JA, Glaser BM, Glaser BM. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol. 1984 Dec. 102(12):1830-3. [QxMD MEDLINE Link].
Campochiaro PA, Kaden IH, Vidaurri-Leal J, Glaser BM. Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol. 1985 Mar. 103(3):434-6. [QxMD MEDLINE Link].
Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology. 2004 Dec. 111(12):2240-5. [QxMD MEDLINE Link].
Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina. 2006 Jul-Aug. 26(6):699-700. [QxMD MEDLINE Link].
Clarkson JG, Green WR, Massof D. A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol. 1977 Jul. 84(1):1-17. [QxMD MEDLINE Link].
Cusick M, Charles MK, Agrón E, Sangiovanni JP, Ferris FL, Charles S. Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity. Retina. 2006 Sep. 26(7):729-35. [QxMD MEDLINE Link].
de Juan E Jr, Sternberg P Jr, Michels RG. Timing of vitrectomy after penetrating ocular injuries. Ophthalmology. 1984 Sep. 91(9):1072-4. [QxMD MEDLINE Link].
Glaser BM, Cardin A, Biscoe B. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology. 1987 Apr. 94(4):327-32. [QxMD MEDLINE Link].
Glaser BM, Vidaurri-Leal J, Michels RG, Campochiaro PA. Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology. 1993 Apr. 100(4):466-70. [QxMD MEDLINE Link].
Greven C, Tasman W. Scleral buckling in stages 4B and 5 retinopathy of prematurity. Ophthalmology. 1990 Jun. 97(6):817-20. [QxMD MEDLINE Link].
Hsu HT, Ryan SJ. Experimental retinal detachment in the rabbit. Penetrating ocular injury with retinal laceration. Retina. 1986 Winter-Spring. 6(1):66-9. [QxMD MEDLINE Link].
Iverson DA, Katsura H, Hartzer MK, Blumenkranz MS. Inhibition of intraocular fibrin formation following infusion of low- molecular-weight heparin during vitrectomy. Arch Ophthalmol. 1991 Mar. 109(3):405-9. [QxMD MEDLINE Link].
Khawly JA, Saloupis P, Hatchell DL, Machemer R. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1991. 229(5):464-7. [QxMD MEDLINE Link].
Kirchhof B. Strategies to influence PVR development. Graefes Arch Clin Exp Ophthalmol. 2004 Aug. 242(8):699-703. [QxMD MEDLINE Link].
Kirmani M, Ryan SJ. In vitro measurement of contractile force of transvitreal membranes formed after penetrating ocular injury. Arch Ophthalmol. 1985 Jan. 103(1):107-10. [QxMD MEDLINE Link].
Lakhanpal RR, Fortun JA, Chan-Kai B, Holz ER. Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity. Retina. 2006 Sep. 26(7):736-40. [QxMD MEDLINE Link].
Maguire AM, Trese MT. Lens-sparing vitreoretinal surgery in infants. Arch Ophthalmol. 1992 Feb. 110(2):284-6. [QxMD MEDLINE Link].
Meredith TA, Kaplan HJ, Aaberg TM. Pars plana vitrectomy techniques for relief of epiretinal traction by membrane segmentation. Am J Ophthalmol. 1980 Mar. 89(3):408-13. [QxMD MEDLINE Link].
Michels RG. Proliferative diabetic retinopathy: Pathophysiology of extraretinal complications and principles of vitreous surgery. Retina. 1981. 1:1-17.
Miller B, Miller H, Patterson R, Ryan SJ. Retinal wound healing. Cellular activity at the vitreoretinal interface. Arch Ophthalmol. 1986 Feb. 104(2):281-5. [QxMD MEDLINE Link].
Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 2002 Jan. 21(1):127-44. [QxMD MEDLINE Link].
Quinn GE, Dobson V, Barr CC, Davis BR, Flynn JT, Palmer EA, et al. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity. Ophthalmology. 1991 Jan. 98(1):5-13. [QxMD MEDLINE Link].
Rachal WF, Burton TC. Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol. 1979 Mar. 97(3):480-3. [QxMD MEDLINE Link].
Schrey S, Krepler K, Wedrich A. Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients. Retina. 2006 Feb. 26(2):149-52. [QxMD MEDLINE Link].
Singh AK, Michels RG, Glaser BM. Scleral indentation following cryotherapy and repeat cryotherapy enhance release of viable retinal pigment epithelial cells. Retina. 1986 Summer-Fall. 6(3):176-8. [QxMD MEDLINE Link].
Stern WH, Lewis GP, Erickson PA, Guerin CJ, Anderson DH, Fisher SK, et al. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol. 1983 Jul. 96(1):33-42. [QxMD MEDLINE Link].
Sun JK, Arroyo JG. Adjunctive therapies for proliferative vitreoretinopathy. Int Ophthalmol Clin. 2004. 44(3):1-10. [QxMD MEDLINE Link].
Tano Y, Sugita G, Abrams G, Machemer R. Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol. 1980 Jan. 89(1):131-6. [QxMD MEDLINE Link].
Trese MT. Visual results and prognostic factors for vision following surgery for stage V retinopathy of prematurity. Ophthalmology. 1986 May. 93(5):574-9. [QxMD MEDLINE Link].
Tseng W, Cortez RT, Ramirez G, Stinnett S, Jaffe GJ. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am J Ophthalmol. 2004 Jun. 137(6):1105-15. [QxMD MEDLINE Link].
Ussmann JH, Lazarides E, Ryan SJ. Traction retinal detachment. A cell-mediated event. Arch Ophthalmol. 1981 May. 99(5):869-72. [QxMD MEDLINE Link].
Vidaurri-Leal J, Hohman R, Glaser BM. Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells. A new approach to the study of proliferative vitreoretinopathy. Arch Ophthalmol. 1984 Aug. 102(8):1220-3. [QxMD MEDLINE Link].
Vidaurri-Leal JS, Glaser BM. Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol. 1984 Sep. 102(9):1376-9. [QxMD MEDLINE Link].
Weiss JF, Belkin M. The effect of penicillamine on posttraumatic vitreous proliferation. Am J Ophthalmol. 1981 Nov. 92(5):625-7. [QxMD MEDLINE Link].
Wickham L, Bunce C, Wong D, McGurn D, Charteris DG. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology. 2007 Apr. 114(4):698-704. [QxMD MEDLINE Link].
Wiedemann P, Lemmen K, Schmiedl R, Heimann K. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol. 1987 Jul 15. 104(1):10-4. [QxMD MEDLINE Link].
Yeo JH, Sadeghi J, Campochiaro PA, Green WR, Glaser BM. Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment. Arch Ophthalmol. 1986 Mar. 104(3):417-21. [QxMD MEDLINE Link].
Yeoh J, Williams C, Allen P, Buttery R, Chiu D, Clark B, et al. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Clin Experiment Ophthalmol. 2008 Jul. 36(5):449-54. [QxMD MEDLINE Link].